RIL
MLYS icon

Rothschild Investment LLC’s Mineralys Therapeutics MLYS Stock Holding History

Rothschild Investment LLC’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19K Sell
81
-11
-12% -$302 ﹤0.01% 2720
2026
Q1 		$2.49K Buy
92
+37
+67% +$1.08K ﹤0.01% 2445
2025
Q4 		$2K Buy
55
+5
+10% +$201 ﹤0.01% 2376
2025
Q3 		$1.9K Sell
50
-25
-33% -$541 ﹤0.01% 2265
2025
Q2 		$1.01K Buy
75
+35
+88% +$507 ﹤0.01% 2460
2025
Q1 		$635 Sell
40
-65
-62% -$748 ﹤0.01% 2540
2024
Q4 		$1.29K Buy
105
+75
+250% +$981 ﹤0.01% 2059
2024
Q3 		$363 Buy
30
+10
+50% +$121 ﹤0.01% 2559
2024
Q2 		$234 Buy
+20
New +$252 ﹤0.01% 2432

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Rothschild Investment LLC's MLYS Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Mineralys Therapeutics (MLYS) stake by 12% in Q2 2026, selling an estimated $302 and leaving 81 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2720.

Rothschild Investment LLC first reported a position in MLYS in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.49K in Q1 2026. 58 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Rothschild Investment LLC held 81 shares of Mineralys Therapeutics worth $2.19K as of Q2 2026.
  • Rothschild Investment LLC sold 11 Mineralys Therapeutics shares in Q2 2026, an estimated $302.
  • Mineralys Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2720 holding.
  • Rothschild Investment LLC first reported a position in Mineralys Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Rothschild Investment LLC's Mineralys Therapeutics position peaked at $2.49K in Q1 2026.
  • 58 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.